E-LIB Suche - Ergebnisse für: Popmihajlov, Zoran

1

CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in pat..:

Popmihajlov, Zoran ; Sutherland, Donna J ; Horan, Gerald S...
BMJ Open Respiratory Research. 9 (2022) 1 - p. e001060 , 2022

Link: https://doi.org/10.1136/..

2

Immunogenicity of Inactivated Varicella Zoster Vaccine in A..:

V212 Protocol 001 Trial Group and V212 Protocol 011 Trial Group ; Popmihajlov, Zoran ; Annunziato, Paula W...
Open Forum Infectious Diseases. 7 (2020) 7 - p. , 2020

Link: https://doi.org/10.1093/..

3

Safety and Immunogenicity of Zoster Vaccine Live in Human I..:

Benson, Constance A ; Andersen, Janet W ; Macatangay, Bernard J C...
Clinical Infectious Diseases. 67 (2018) 11 - p. 1712-1719 , 2018

Link: https://doi.org/10.1093/..

4

Immunogenicity and safety of zoster vaccine live administer..:

Levin, Myron J. ; Buchwald, Ulrike K. ; Gardner, Julie...
Vaccine. 36 (2018) 1 - p. 179-185 , 2018

Link: https://doi.org/10.1016/..

5

Persistence of Varicella-Zoster Virus Cell-Mediated Immunit..:

Weinberg, Adriana ; Popmihajlov, Zoran ; Schmader, Kenneth E...
The Journal of Infectious Diseases. 219 (2018) 2 - p. 335-338 , 2018

Link: https://doi.org/10.1093/..

6

Safety and Immunogenicity of Inactivated Varicella-Zoster V..:

Eberhardson, Michael ; Hall, Stephen ; Papp, Kim A...
Clinical Infectious Diseases. 65 (2017) 7 - p. 1174-1182 , 2017

Link: https://doi.org/10.1093/..

7

Herpes zoster vaccine live: A 10 year review of post-market..:

Willis, English D. ; Woodward, Meredith ; Brown, Elizabeth...
Vaccine. 35 (2017) 52 - p. 7231-7239 , 2017

Link: https://doi.org/10.1016/..

8

Immunogenicity of Inactivated Varicella Zoster Vaccine (ZVI..:

Boeckh, Michael ; Arvin, Ann ; Mullane, Kathleen...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S60-S60 , 2017

Link: https://doi.org/10.1093/..

9

A Phase III, Double-Blind, Randomized, Placebo-Controlled, ..:

Winston, Drew J. ; Mullane, Kathleen M. ; Boeckh, Michael J....
Biology of Blood and Marrow Transplantation. 23 (2017) 3 - p. S24-S25 , 2017

Link: https://doi.org/10.1016/..

10

Safety and Immunogenicity of Inactivated Varicella-Zoster V..:

Eberhardson, Michael ; Hall, Stephen ; Papp, Kim A....
Clinical Infectious Diseases. 65 (2017) 7 - p. 1174-1182 , 2017

Link: https://www.jstor.org/st..

11

Immune Senescence Factors Associated with the Immunogenicit..:

Weinberg, Adriana ; Schamder, Kenneth ; Johnson, Michael...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S413-S414 , 2017

Link: https://doi.org/10.1093/..

12

Evaluation of two doses of etoricoxib, a COX-2 selective no..:

Bickham, Kara ; Kivitz, Alan J. ; Mehta, Anish...
BMC Musculoskeletal Disorders. 17 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

13

A randomized, clinical trial to assess the relative efficac..:

Balazcs, Eva ; Sieper, Joachim ; Bickham, Kara...
BMC Musculoskeletal Disorders. 17 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

14

Cellular and Humoral Responses to a Second Dose of Herpes Z..:

Levin, Myron J. ; Schmader, Kenneth E. ; Pang, Lei...
The Journal of Infectious Diseases. 213 (2016) 1 - p. 14-22 , 2016

Link: http://www.jstor.org/sta..

15

Varicella Zoster Virus (VZV) Cell-Mediated Immunity 3 Years..:

Weinberg, Adriana ; Levin, Myron ; Schmader, Kenneth...
Open Forum Infectious Diseases. 3 (2016) suppl_1 - p. , 2016

Link: https://doi.org/10.1093/..